Jason Lin

Liver-specific amino acid metabolism impacts on efficacy of cancer immunotherapy

Abstract The combination immunotherapies, including those with atezolizumab and bevacizumab (Atez/Bev), have become standard therapy for hepatocellular carcinoma (HCC). However, its efficacy remains limited and reliable biomarkers are lacking. In this study, we analyzed paired tu...